Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jeffrey

Showing results (301-310 of 744) with videos related to

Pageof 75
Sort By:
Journal of Substance Abuse Treatment|May 24, 2006
Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials NetworkLawrence S Brown, Steven Allan Kritz, R Jeffrey Goldsmith, et al.
The Journal of Urology|February 22, 2008
Assessing the value of reflex fluorescence in situ hybridization testing in the diagnosis of bladder cancer when routine urine cytological examination is equivocalBenjamin R Kipp, Kevin C Halling, Michael B Campion, et al.
The EMBO Journal|March 11, 2017
AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interactionChun-Wu Pan, Xin Jin, Yu Zhao, et al.
The Journal of Molecular Diagnostics : JMD|January 31, 2009
Quantitative fluorescence in situ hybridization and its ability to predict bladder cancer recurrence and progression to muscle-invasive bladder cancerBenjamin R Kipp, Mihaela Tanasescu, Terry A Else, et al.
The Journal of Urology|July 17, 2007
Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen eraStephen A Boorjian, R Houston Thompson, Sameer Siddiqui, et al.
Journal of the Egyptian Society of Parasitology|May 6, 2004
Diagnostic microarray: an array of possibilities for parasitologyA Fadiel, A D Kovac, R Jeffrey, et al.
The Journal of Urology|November 18, 2008
The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomyStephen A Boorjian, R Jeffrey Karnes, Paul L Crispen, et al.
Cancer|May 7, 2003
Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcomeIgor Frank, John C Cheville, Michael L Blute, et al.
European Urology|March 11, 2011
Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrenceStephen A Boorjian, R Houston Thompson, Matthew K Tollefson, et al.
Archivos Espanoles De Urologia|May 8, 2013
Current role of surgery for high risk prostate cancerSteven Joniau, Kathy Van der Eeckt, Alberto Briganti, et al.
Pageof 75

Showing results (301-310 of 744) with videos related to

Sort By:
Pageof 75
Journal of Substance Abuse Treatment|May 24, 2006
Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials NetworkLawrence S Brown, Steven Allan Kritz, R Jeffrey Goldsmith, et al.
The Journal of Urology|February 22, 2008
Assessing the value of reflex fluorescence in situ hybridization testing in the diagnosis of bladder cancer when routine urine cytological examination is equivocalBenjamin R Kipp, Kevin C Halling, Michael B Campion, et al.
The EMBO Journal|March 11, 2017
AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interactionChun-Wu Pan, Xin Jin, Yu Zhao, et al.
The Journal of Molecular Diagnostics : JMD|January 31, 2009
Quantitative fluorescence in situ hybridization and its ability to predict bladder cancer recurrence and progression to muscle-invasive bladder cancerBenjamin R Kipp, Mihaela Tanasescu, Terry A Else, et al.
The Journal of Urology|July 17, 2007
Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen eraStephen A Boorjian, R Houston Thompson, Sameer Siddiqui, et al.
Journal of the Egyptian Society of Parasitology|May 6, 2004
Diagnostic microarray: an array of possibilities for parasitologyA Fadiel, A D Kovac, R Jeffrey, et al.
The Journal of Urology|November 18, 2008
The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomyStephen A Boorjian, R Jeffrey Karnes, Paul L Crispen, et al.
Cancer|May 7, 2003
Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcomeIgor Frank, John C Cheville, Michael L Blute, et al.
European Urology|March 11, 2011
Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrenceStephen A Boorjian, R Houston Thompson, Matthew K Tollefson, et al.
Archivos Espanoles De Urologia|May 8, 2013
Current role of surgery for high risk prostate cancerSteven Joniau, Kathy Van der Eeckt, Alberto Briganti, et al.
Pageof 75